Search
for
Sort by
Research 30 of 115
- 645 MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
- 646 SOX4 is essential for melanoma tumorigenesis
- Is knowledge about the genetic and epigenetic alterations in melanoma a basis for targeted therapy?
- Inducible cre-mediated N-ras activation and PTEN inactivation in transgenic mouse melanocytes requires keratinocyte hyperplasia to elicit a melanocyte pathology
- 642 Uncovering the role of UV exposure history and genetics in determining skin sun damage
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- Targeted therapy in melanoma
- Lentiginous melanoma. A clinically malignant entity that histopathologically seems benign. Case study harbouring BRAF V 600R mutation
- B‐ RAF , naevi and melanoma: a complex relationship
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
- 643 Male pattern baldness and risk of incident skin cancer in a cohort of men
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Clinical, Dermoscopic, and Histological Characteristics of Melanoma Patients According to the Age Groups: A Retrospective Observational Study
- Editor's evaluation: Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma
- A cross-sectional study of clinical, dermoscopic, histopathological, and molecular patterns of scalp melanoma in patients with or without androgenetic alopecia
- A Short Report on Melanocyte/Melanoma Culture, Senescence, and Reproducibility
- RAGE and Its Ligands in Melanoma
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- The molecular pathogenesis of Trichilemmal carcinoma
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Topical delivery of nanoemulsions for skin cancer treatment
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
- Research Techniques Made Simple: Zebrafish Models for Human Dermatologic Disease
- Spectrum of Phenotypes Associated with Human MC1R Variations
- Contents
- Melanocytes: The new Black
- MicroRNA in skin diseases